Language selection

Government of Canada / Gouvernement du Canada

Search

Biosimilars in Canada : policies to promote switching and what it means for payers.: H82-60/2025E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.965445&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleBiosimilars in Canada : policies to promote switching and what it means for payers.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Les médicaments biosimilaires au Canada : politiques visant à favoriser la substitution et ce qu'elles signifient pour les payeurs.
  • "Presentation to the 2025 Annual CAHSPR Conference, May 2025."
  • "Presented by: Yvonne Zhang, Senior Economist."
  • "NPDUIS Research Initiative, Patented Medicine Prices Review Board."
Publishing information
  • [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025]
Author / Contributor
  • Zhang, Yvonne.
Description1 online resource (11 pages) : colour illustrations
Catalogue number
  • H82-60/2025E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: